Aptevo Therapeutics Inc (APVO) Stock Price

4.86 ▼ -0.08 (-1.62%)
Open: 4.95 Vol: 27.3K Day's range: 4.7001 - 4.96 May 07, 16:00 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
APVO Technical Analysis
5 mins 30 mins Hourly Daily Weekly
BUY BUY BUY SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 4.83▲ 4.84▲ 4.84▲ 5.10▼ 4.87▼
MA10 4.84▲ 4.87▲ 4.88▲ 4.99▼ 4.82▲
MA20 4.87▲ 4.87▲ 4.92▲ 5.03▼ 6.05▼
MA50 4.88▲ 4.97▼ 4.87▲ 5.05▼ 3.76▲
MA100 4.87▲ 4.62▲ 4.62▲ 5.73▼ 18.45▼
MA200 4.62▲ 5.04▼ 5.44▼ 3.72▲ 26.66▼
  5 mins 30 mins Hourly Daily Weekly
MACD 0.003▲ 0.000▼ -0.015▼ 0.020▲ 0.051▲
RSI 53.482▲ 51.321▲ 50.218▲ 47.196▼ 46.527▼
STOCH 55.970     51.244     63.016     44.228     25.902    
WILL %R -16.418▲ -16.418▲ -19.977▲ -59.375     -74.407    
CCI 49.850     66.952     79.875     -69.037     -36.385    
Latest Filters Detected On APVO
RSI $APVO RSI(14) Crossed Below 50 Set Alert
MA $APVO Price Crossed Below MA(50) Set Alert
MA $APVO Price Crossed Below MA(13) Set Alert
MA $APVO Price Crossed Below MA(7) Set Alert
▼ GAP $APVO Open Gap Down %5 Set Alert
▼ GAP $APVO Open Gap Down %3 Set Alert
▼ GAP $APVO Open Gap Down %2 Set Alert
Aptevo Therapeutics Inc News
Aptevo Reports 87% Clinical Benefit and 81% Remission in 31 Evaluable Frontline AML Patients Through Cohort 5, Substantially Outperforming Benchmark; RAINIER on Track for 2026 ...
Wednesday, May 06, 2026 05:27 AM
Program Enters Final Stage of Dose Optimization Data Continue to Demonstrate Strong Clinical Activity and Favorable Safety Across an Expanding Frontline Dataset SEATTLE, WA / ACCESS Newswire / May 6, ...
Aptevo Therapeutics: Aptevo Reports 87% Clinical Benefit and 81% Remission in 31 Evaluable Frontline AML Patients Through Cohort 5, Substantially Outperforming Benchmark ...
Wednesday, May 06, 2026 05:26 AM
Program Enters Final Stage of Dose OptimizationData Continue to Demonstrate Strong Clinical Activity and Favorable Safety Across an Expanding Frontline Dataset SEATTLE, WA / ACCESS Newswire / May 6, 2 ...
Aptevo to Participate in March 2026 Conferences
Thursday, March 19, 2026 05:05 AM
SEATTLE, WA / ACCESS Newswire / March 19, 2026 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage biotechnology company developing novel immune-oncology therapeutics based on its proprietary ...
APVO historical stock data
date open high low close volume
07/05/26 4.95 4.96 4.7001 4.86 27,301
06/05/26 4.55 5.02 4.34 4.94 461,739
05/05/26 5.5165 5.5165 5.23 5.35 13,888
04/05/26 5.09 5.62 4.96 5.45 43,191
01/05/26 4.86 4.968 4.86 4.92 4,236
30/04/26 4.8401 5.0041 4.8401 4.85 4,699
29/04/26 4.7736 5.00 4.7736 4.81 13,386
28/04/26 5.00 5.00 4.80 4.905 19,020
27/04/26 4.81 5.00 4.80 4.92 13,493
24/04/26 4.9999 4.9999 4.8001 4.87 28,926
Quote Details
52wk Low:0.504
52wk High:14.334
Vol:27.3K
Avg Vol(3m):990.3K
1Y Chng:-11.76%
1M Chng:+7.76%
Add to Watch List
More Information
Index US Composite
Market Cap. 5.84M